Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in contract manufacturing activities for pharmaceutical companies. Quest Laboratories Limited was founded in 1994 and is based in Dhar, India.
| Current Price | ₹90.20 |
|---|---|
| Market Cap | ₹151 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 9.9 |
| Return on Equity | 16.82% |
| 52-Week Range | ₹68.60 – ₹152.60 |
| Beta (1Y) | 0.58 |
| Revenue | ₹32 Cr |
|---|---|
| Net Profit | ₹3 Cr |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Drugs And Chemicals-100%
Quest Laboratories Limited is trading at ₹90.20, with a market capitalisation of ₹151 Cr.
Quest Laboratories Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Quest Laboratories Limited has a P/E of 9.9 and a return on equity of 16.82%.
In Q4 FY26, Quest Laboratories Limited reported revenue of ₹32 Cr and net profit of ₹3 Cr (standalone, parsed from the company's exchange filing).